- Home
- DFIN vs IRON Comparison
DFIN vs IRON Comparison
Compare DFIN & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DFIN
- IRON
- Stock Information
- Founded
- DFIN 1983
- IRON 2017
- Country
- DFIN United States
- IRON United States
- Employees
- DFIN N/A
- IRON N/A
- Industry
- DFIN Other Consumer Services
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- DFIN Consumer Discretionary
- IRON Health Care
- Exchange
- DFIN Nasdaq
- IRON Nasdaq
- Market Cap
- DFIN 1.8B
- IRON 2.1B
- IPO Year
- DFIN N/A
- IRON N/A
- Fundamental
- Price
- DFIN $64.41
- IRON $60.61
- Analyst Decision
- DFIN Strong Buy
- IRON Strong Buy
- Analyst Count
- DFIN 3
- IRON 12
- Target Price
- DFIN $68.67
- IRON $92.08
- AVG Volume (30 Days)
- DFIN 199.1K
- IRON 380.3K
- Earning Date
- DFIN 07-31-2025
- IRON 08-07-2025
- Dividend Yield
- DFIN N/A
- IRON N/A
- EPS Growth
- DFIN N/A
- IRON N/A
- EPS
- DFIN 3.01
- IRON N/A
- Revenue
- DFIN $779,600,000.00
- IRON N/A
- Revenue This Year
- DFIN $1.99
- IRON N/A
- Revenue Next Year
- DFIN $4.64
- IRON N/A
- P/E Ratio
- DFIN $21.39
- IRON N/A
- Revenue Growth
- DFIN N/A
- IRON N/A
- 52 Week Low
- DFIN $37.80
- IRON $30.82
- 52 Week High
- DFIN $71.01
- IRON $68.73
- Technical
- Relative Strength Index (RSI)
- DFIN 65.91
- IRON 66.93
- Support Level
- DFIN $60.87
- IRON $57.42
- Resistance Level
- DFIN $62.60
- IRON $61.73
- Average True Range (ATR)
- DFIN 1.41
- IRON 2.32
- MACD
- DFIN -0.23
- IRON 0.26
- Stochastic Oscillator
- DFIN 66.61
- IRON 84.88
About DFIN Donnelley Financial Solutions Inc.
Donnelley Financial Solutions Inc is a risk and compliance solutions company. The company provides regulatory filing and deal solutions via its software-as-a-service, technology-enabled services, and print and distribution solutions to public and private companies, mutual funds, and other regulated investment firms. The company operates in four segments: Capital Markets - Software Solutions, Capital Markets - Compliance and Communications Management, Investment Companies - Software Solutions and Investment Companies - Compliance and Communications Management. Its geographical segments are the United States( USA), Europe, Asia, Canada, and others, of which the USA accounts for the vast majority of its total revenue.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.